MedPath

Neuroplastic Change in Myelin of the Brain

Not Applicable
Conditions
Stroke
Interventions
Behavioral: TRAIT Task
Registration Number
NCT01937910
Lead Sponsor
University of British Columbia
Brief Summary

The main goal of this research is to advance understanding of how stroke changes both the structure and function of the brain. The investigators will determine which is the key driver of recovery of arm function after stroke: changes in the structure of the brain or changes in how brain regions interact with one another.

Detailed Description

The main goal of this research is to advance understanding of how stroke changes both the structure and function of the brain. Further, the investigators will determine which is the key driver of recovery of arm function after stroke: changes in the structure of the brain or changes in how brain regions interact with one another. Together, these data will advance the investigators understanding of how neural systems support recovery from stroke. The investigators will use a MRI technique that allows us to assess the health of a brain structure called myelin. This structure is important as it allows information to travel down nerves faster; the more myelin the quicker the signal can be conducted. The investigators aim is to test whether or not movement training can restore myelin in the brain. If movement training does restore myelin in the brain, the investigators will have identified an important new target for rehabilitation interventions.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
88
Inclusion Criteria
  • individuals aged 40-75
  • movement-related deficits associated with a middle cerebral artery stroke
  • first time stroke affecting the corona radiata and/or internal capsule
  • Fugl-Meyer upper extremity motor score of at least 15 but not greater than 55.
Read More
Exclusion Criteria
  • outside the age range of 40-75
  • show signs of dementia (score < 24 on the Montreal Cognitive Assessment)
  • have aphasia (score < 13 on the Frenchay Aphasia Screen)
  • history of head trauma, a major psychiatric diagnosis, neurodegenerative disorder or substance abuse;
  • taking any drugs (GABAergic, N-methyl-D-aspartate A-receptor (NMDA) antagonist) known to influence neuroplasticity;
  • report contraindications to MRI (see supporting documents)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Stroke GroupTRAIT TaskParticipants in the stroke group will complete 10 training sessions of the TRAIT task.
Matched Healthy Control GroupTRAIT TaskParticipants in the Matched Healthy Control group will complete 10 sessions of the TRAIT task
Primary Outcome Measures
NameTimeMethod
Change in Myelin water fractionBaseline and 30 days post baseline

Myelin water fraction (MWF) is the area of the short T2 component (15-35ms) divided by the total T2 distribution expressed as a percentage (MWF% = MWF\*100)

Secondary Outcome Measures
NameTimeMethod
Change in Fractional anisotropyBaseline and 30 days post baseline

Diffusion properties will be defined by calculating a 6-element tensor ellipsoid to provide both the magnitude and direction of diffusivity in a local orthogonal coordinate system within each voxel. Fractional anisotropy (FA) will be calculated to provide an index of microstructural white matter integrity.

Trial Locations

Locations (1)

University of British Columbia

🇨🇦

Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath